Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

NNASDAQ:ELVN
47.62
USD
-1.18
(-2.42%)
-1.69EPS
3.37BMarket Cap
Mar 18Next Earn

Latest Stock Split

Feb 24, 2023

1:4

For every 4 shares held, investors received 1. The price per share adjusted from $6.32 to $25.28.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Feb 24, 2023
    Before$6.32
    Split ratio1:4
    After$25.28
    Reverse

About Enliven Therapeutics, Inc. stock splits

Enliven Therapeutics, Inc. (NASDAQ:ELVN) operates in the Biotechnology industry.

Enliven Therapeutics, Inc. company overview

When did Enliven Therapeutics, Inc. stock split?

Enliven Therapeutics, Inc.'s most recent stock split was on February 24, 2023. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.

How many times has Enliven Therapeutics, Inc. stock split?

Enliven Therapeutics, Inc. has split its stock once. This history records one reverse split, on February 24, 2023.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Enliven Therapeutics, Inc.'s 1-for-4 reverse split on February 24, 2023, every 4 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Enliven Therapeutics, Inc. split its stock again?

Enliven Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on February 24, 2023, 3 years ago. Companies announce splits in advance, and any new NASDAQ:ELVN split will appear on this page.